{"id":431926,"title":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2024-04-30] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T06:55:27.074000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2024-04-30.html","snippet":"Notice: Multiple Additions to the Prescription Drug List (PDL) [2024-04-30] April 30, 2024 Our file number: 24-103562-165 The purpose of this Notice of Amendment is to notify about the addition of capivasertib, etrasimod and olipudase alfa to the Prescription Drug List (PDL) for…","rawSnapshotUrl":"/api/snapshots/raw/431926","browseUrl":"https://replay.healtharchive.ca/job-6/20260102065527/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2024-04-30.html#ha_snapshot=431926","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}